1478833

Orlistat Related Compound C

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): Triphenylphosphine oxide, Ph₃PO, TPPO, Triphenyl phosphorus oxide, Triphenylphosphine monoxide
• Linear Formula: (C₆H₅)₃PO
• CAS Number: 791-28-6
• Molecular Weight: 278.28
• Beilstein: 745854
• MDL number: MFCD00002080
• UNSPSC Code: 41116107
• PubChem Substance ID: 329750619
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: orlistat
• manufacturer/tradename: USP
• mp: 150-157 °C (lit.)
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: O=P(c1ccccc1)(c2ccccc2)c3ccccc3
• InChI: 1S/C18H15OP/c19-20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H
• InChI key: FIQMHBFVRAXMOP-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Orlistat Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Latanoprost
• Orlistat

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H302,H412
• Precautionary Statements: P264 - P270 - P273 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 3
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable